后退 发表于 2025-3-25 03:50:09

http://reply.papertrans.cn/83/8270/826983/826983_21.png

规范要多 发表于 2025-3-25 08:44:15

http://reply.papertrans.cn/83/8270/826983/826983_22.png

unstable-angina 发表于 2025-3-25 13:19:48

http://reply.papertrans.cn/83/8270/826983/826983_23.png

你正派 发表于 2025-3-25 19:22:24

Angiopoietins and Other Non-VEGF Antiangiogenic Targets in Advanced Renal Cell Carcinoma

听觉 发表于 2025-3-25 23:39:48

Epigenetic Targeting and Histone Deacetylase Inhibition in RCC

慢慢流出 发表于 2025-3-26 01:16:15

http://reply.papertrans.cn/83/8270/826983/826983_26.png

郊外 发表于 2025-3-26 07:07:19

http://reply.papertrans.cn/83/8270/826983/826983_27.png

Classify 发表于 2025-3-26 10:10:21

Carbonic Anhydrase IX: Its Role as a Biomarker, Diagnostic, and Therapeutic Target in Renal Cell Car

coltish 发表于 2025-3-26 14:44:28

Presurgical Therapy for Renal Cell Carcinoma and Implications for Window-of-Opportunity Trials

飞来飞去真休 发表于 2025-3-26 18:49:21

Mechanisms of Resistance to VEGF-Directed Therapy and Implications for Future Trial Design
页: 1 2 [3] 4 5 6
查看完整版本: Titlebook: Renal Cell Carcinoma; Translational Biolog Robert A. Figlin,W. Kimryn Rathmell,Brian I. Rini Book 2012 Springer Science+Business Media, LLC